Daniel Carcillo

“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB: WSNAF) at Benzinga Psychedelics...

This article was originally published on Psychedelic Spotlight and appears here with permission. Professional athletes and men’s wellness gurus are turning to psychedelics to explore their inner selves. What's going on with psychedelic masculinity? What is American masculinity in 2022? A...

Life sciences company Wesana Health (OTCQB: WSNAF) has completed the sale of its indirect, wholly-owned subsidiary Advanced Psychiatric Management LLC for a total of $2,100,000. The equity purchase agreement will hand over the Chicago-based Management Services Organization (MSO) assets to APS...

Field Trip (NASDAQ: FTRP), Wesana (OTCQB: WSNAF), Braxia (OTC: BRAXF) and Irwin Naturals (OTC: IWINF) released their quarterly results. Field Trip Health & Wellness Ltd.  Psychedelic-assisted therapy provider Field Trip (TSXV: FTHW) reported its fiscal and business results...

Daniel Carcillo is co-founder and CEO of Wesana Health (OTC: WSNAF), a data-driven life sciences company pioneering clinical therapies and drug development through the FDA pathway. A former NHL star, Carcillo won two Stanley Cups before retiring at the age of 30 due to Post-Concussion Syndrome...

Wesana Health Holdings Inc. (OTCQB: WSNAF) (CSE:WESA) have received a full written response from the Food and Drug Administration regarding their pre-investigational new drug meeting for the novel therapy and proprietary protocol of SANA-013 for the treatment of traumatic brain injury related...

This article by Sarah Abelsohn was originally published on Psychedelic Spotlight and appears here with permission. During our time at Wonderland Miami, $PSYC CEO, David Flores, had the pleasure of sitting down with Wesana Health (OTC: WSNAF) CEO, Daniel Carcillo, to talk about the...

On Tuesday, Wesana Health Holdings (CSE: WESA), a life science company that champions the development of psychedelics and other medicines for the treatment of traumatic brain injury, announced a definitive agreement to acquire PsyTech Inc. in an all-stock transaction for approximately CA$21...

On Monday, Wesana Health Holdings Inc. announced that its shares began trading on the Canadian Securities Exchange under the ticker symbol “WESA.” The company, founded by former NHL left-winger Daniel Carcillo, is focused on finding novel solutions for treating traumatic brain injury (...

MindMed Posts 2020 Financials, New MDMA Dosing Study and 18-MC Patent Application MindMed (OTCQB:MMEDF) released its full-year 2020 financial results.  The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the...

First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund went public last Wednesday. The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK’, and managed by Horizons ETFs Management. PSYK is a...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Researchers say psychedelics like ayahuasca, psilocybin, ketamine, ibogaine and 5-MeO-DMT prove so beneficial to professional athletes because they have the ability to...